Operative and Midterm Outcomes of the Fenestrated Anaconda Stent-Graft in the Endovascular Treatment of Juxtarenal, Suprarenal, and Type IV Thoracoabdominal Aortic Aneurysms

Conclusion: FEVAR with the Anaconda device delivers satisfactory short-term technical and clinical success rates in patients with juxtarenal, suprarenal, and type IV TAAA. Midterm efficacy and durability with respect to aneurysm sac regression and target vessel patency appear very good. Overall mortality and the need for reintervention were significant in this patient cohort.

Source: Journal of Endovascular Therapy - November 5, 2016 Category: Surgery Authors: Kotelis, D., Schleimer, K., Foldenauer, C., Jalaie, H., Grommes, J., Jacobs, M. J., Kalder, J. Tags: Endovascular Aneurysm Repair Source Type: research